Merck

MRK: How Merck's Stock Price Rose 31.42% in 6 Months
Investopedia
Mon, 09/5/16 - 10:01 am
Merck
diabetes
immunotherapy
Opdivo
Bristol-Myers Squibb
Keytruda
Merck scraps development of osteoporosis drug due to stroke risk
Yahoo/Reuters
Fri, 09/2/16 - 09:47 am
Merck
osteoporosis
stroke
Odanacatib
Merck Will Hold Steady on Div Increase Despite Flat Revenue Growth
Yahoo/GuruFocus
Thu, 09/1/16 - 09:24 am
Merck
dividends
Merck: Lung Cancer Lead Depends On “How Smart It Plays Its Hand”
Barron's
Wed, 08/31/16 - 08:54 pm
Merck
Bristol-Myers Squibb
lung cancer
Keytruda
Opdivo
Merck & Co., Inc. Gears Up For Extended Reach In Immunotherapies Race
Bidness, ETC
Fri, 08/26/16 - 09:58 am
Merck
Keytruda
Opdivo
Bristol-Myers Squibb
Lung cancer doctors eye Merck's Keytruda over Bristol's Opdivo
Yahoo/Reuters
Thu, 08/25/16 - 09:25 pm
lung cancer
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
Merck Potential Blockbuster Drug, Key Acquisition Make It a Good Bet for Investors
TheStreet.com
Tue, 08/23/16 - 05:44 pm
Keytruda
Merck
GSK, Merck shares win as 2016 brings big moves. Losers? You know who
Fierce Pharma
Tue, 08/23/16 - 10:00 am
GSK
Merck
Valeant Pharmaceuticals
Endo International
Sagent Pharmaceuticals
Alkermes
Shire
Perrigo
Medivation shares pop after report that at least five companies interested in deal
CNBC
Thu, 08/18/16 - 09:53 am
Medivation
M&A
Merck
Sanofi
Gilead Sciences
Celgene
Pfizer
Merck enters race for cancer drugmaker Medivation - sources
Reuters
Wed, 08/17/16 - 04:18 pm
Merck
Medivation
M&A
Sanofi
Pfizer
Celgene
Gilead Sciences
Merck cutting 148 Montco jobs
Bizjournals.com
Wed, 08/17/16 - 10:43 am
Merck
layoffs
Why Gardasil Is So Important to Merck’s Vaccines Business
Market Realist
Tue, 08/16/16 - 09:19 am
Gardasil
vaccines
Merck
HPV
Recent FDA Approvals - Aug 15 2016
CP Wire
Mon, 08/15/16 - 03:50 pm
Aurobindo
Merck
FDA
drug approvals
Sun Pharma
Santarus
Keytruda
Boston Scientific
devices
Heron Therapeutics
What Are Merck’s Key Diabetes Products?
Market Realist
Mon, 08/15/16 - 11:05 am
Merck
diabetes
Januvia
Janumet
Gilead to get attorney fees in hepatitis C patent fight with Merck
Yahoo/Reuters
Thu, 08/11/16 - 11:35 pm
Gilead Sciences
Merck
hepatitis C
Sovaldi
Harvoni
Why Merck’s Lung Cancer Success Won’t Last
Barron's
Tue, 08/9/16 - 10:39 am
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
non-small cell lung cancer
Opdivo bet backfires, creates opening for Merck to pursue DTC
Medical Marketing and Media
Mon, 08/8/16 - 11:18 am
Opdivo
Merck
Bristol-Myers Squibb
Keytruda
DTC advertising
Will Merck Pay A 29% Premium for Biogen?
Forbes
Thu, 08/4/16 - 10:02 am
Biogen
Merck
Allergan
M&A
Biogen: Allergan or Merck? Neither
Barron's
Thu, 08/4/16 - 09:49 am
Biogen
M&A
Merck
Allergan
Merck’s KEYTRUDA® (pembrolizumab) Approved by the European Commission for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Whose Tumors Express PD-L1
Yahoo
Wed, 08/3/16 - 09:02 am
Merck
Keytruda
Europe
non-small cell lung cancer

Pages